Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial ...

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

Chemotherapy doesn’t just attack cancer cells; it often takes the nervous system along for the ride. In the first month after treatment, about 68% of patients develop chemotherapy-induced peripheral ...

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee?

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in May 2025.